CALL US +46 70 799 2896
Patent Impact
Patent Impact – Transforming Healthcare with AI
Welcome to the heart of BraineHealth’s innovation. Our US Patent 11,908,579 B2 powers Diagnosio, an AI-driven virtual doctor that redefines diagnostics through groundbreaking inversion technology. Featured in BizWeekly.com, AP, and 450+ U.S. outlets, this patent is poised to lead the $500 billion AI healthcare market by 2032. Explore its impact, technology, and partnership opportunities below.
Patent Impact Highlights
A New Era of Diagnostic Intelligence
- Unlike traditional AI tools that predict diagnoses from symptoms, our patented inversion technology evaluates every possible next step—tests, questions, or observations—to recommend the one that maximizes diagnostic certainty. This dynamic decision-making, validated by a 2018 KTH Royal Institute of Technology thesis, achieved 99% accuracy in simulations.
- Scalable to handle over 20,000 cases, 6,000 diagnoses, and 200,000 observables, Diagnosio outperforms competitors like Microsoft’s MAI-DxO by focusing on optimal outcomes, not just predictions.
Healthcare Revolution
Leading the AI Healthcare Revolution
- The global AI healthcare market is projected to exceed $500 billion by 2032, and our patent positions BraineHealth at the forefront. Built years before AI hype—secured with a U.S. patent in February 2024—this foresight is validated by features in BizWeekly.com ("The Founder Who Built a Virtual Doctor Before AI Was Cool") and AP coverage highlighting its global potential.
- With 450+ U.S. outlet placements, the buzz is undeniable. This technology extends beyond medicine to finance, engineering, and cybersecurity, offering versatile licensing opportunities.
Why partner with us?
Unlock Game-Changing Opportunities
- Join investors and collaborators in scaling Diagnosio’s patented AI. Our inversion technology reduces diagnostic costs, speeds up decisions, and enhances patient outcomes—proven by rigorous research and real-world potential.
- Whether for healthcare optimization, financial risk assessment, or engineering diagnostics, this patent offers a first-mover advantage. License it to integrate with your platforms or co-develop with us.
In the media
In the Spotlight
- Our patent’s impact is recognized worldwide. BizWeekly.com celebrates Roger Svensson’s visionary journey, while AP and 450+ U.S. outlets amplify its global reach. This media validation underscores our leadership in AI diagnostics.
- Explore the full coverage and join the conversation driving healthcare’s future.
